Web Analytics Made Easy -


Our Recent Posts



Protavio's MelPlex team at the European Workshops on Cell Death

Protavio presented its latest work on melanoma research at the 11th European Workshops on Cell Death and 3rd MelPlex Annual Meeting held in Fiuggi, Italy, between 4-11th May. Protavio's Jan Rozanc presented his latest findings on how "phosphoprotein patterns allow prediction of trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma." The work is part of the MelPlex program, a Horizon 2020 Marie Curie Action, that aims to improve our understanding on the mechanisms underpinning melanoma in a systems oriented framework and generate a solid basis for the development and validation of diagnostic and predictive tools for personalised cancer therapies. In his talk at

UK: Protavio Ltd, The Bradfield Centre, 184 Cambridge Science Park, Cambridge, CB4 0GA
GR: ProtATonce Ltd, Demokritos Science Park, Patriarchou Grigoriou & Neapoleos, 15343 Ag. Paraskevi, Athens.

©2020 by Protavio / ProtATonce Ltd